Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.62 CAD | +1.25% | 0.00% | -9.50% |
May. 13 | RBC on Oncolytics Biotech's Upcoming Type C Meeting With FDA | MT |
May. 09 | Oncolytics Biotech Reports a First-Quarter Loss of Near $7 Million | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.50% | 88.2M | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- ONC Stock
- News Oncolytics Biotech Inc.
- RBC Capital Keeps OutperformSpeculative on Oncolytics Biotech